Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3301388 | Gastroenterology Clinics of North America | 2008 | 14 Pages |
Abstract
The manifestations of gastroesophageal reflux disease (GERD) have been classified into either esophageal or extraesophageal syndromes. Cough, reflux laryngitis, and asthma have been classified as extraesophageal syndromes, whereas reflux chest pain has been classified as a symptomatic syndrome of GERD. In extraesophageal syndromes, patients usually do not display the classic symptoms of reflux, such as heartburn and regurgitation. Upper gastrointestinal endoscopy and pH monitoring, when used to diagnose reflux in patients with symptoms not classic for GERD, have proved to have poor sensitivity and are often not diagnostically helpful. In contrast, an empiric trial of proton pump inhibitors is a well-established, cost-effective tool.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jeanetta Walters Frye, Michael F. Vaezi,